Klebsiella pneumoniae CIP 52.235 is a bacterium of the family Enterobacteriaceae.
Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Klebsiella |
| Species Klebsiella pneumoniae |
| Full scientific name Klebsiella pneumoniae (Schroeter 1886) Trevisan 1887 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Name | Growth | Composition | Medium link | |
|---|---|---|---|---|---|
| 35541 | MEDIUM 3 - Columbia agar | Columbia agar (39.000 g);distilled water (1000.000 ml) | |||
| 35541 | CIP Medium 3 | Medium recipe at CIP |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 35541 | positive | growth | 30 |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 35541 | 2 | Risk group (French classification) |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Characterization of a Lytic Bacteriophage and Demonstration of Its Combined Lytic Effect with a K2 Depolymerase on the Hypervirulent Klebsiella pneumoniae Strain 52145. | Pertics BZ, Kovacs T, Schneider G. | Microorganisms | 10.3390/microorganisms11030669 | 2023 | ||
| Enzymology | Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates. | Horvath M, Kovacs T, Koderivalappil S, Abraham H, Rakhely G, Schneider G. | Sci Rep | 10.1038/s41598-020-62691-8 | 2020 | |
| Isolation and Characterization of a Novel Lytic Bacteriophage against the K2 Capsule-Expressing Hypervirulent Klebsiella pneumoniae Strain 52145, and Identification of Its Functional Depolymerase. | Pertics BZ, Cox A, Nyul A, Szamek N, Kovacs T, Schneider G. | Microorganisms | 10.3390/microorganisms9030650 | 2021 | ||
| Phylogeny | Molecular serotyping of Klebsiella species isolates by restriction of the amplified capsular antigen gene cluster. | Brisse S, Issenhuth-Jeanjean S, Grimont PA. | J Clin Microbiol | 10.1128/jcm.42.8.3388-3398.2004 | 2004 | |
| Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection. | Yu M, Wu S, Qi B, Wu X, Deng X. | Biomed Rep | 10.3892/br.2023.1634 | 2023 | ||
| PoCUS for the management of Fournier's gangrene in the emergency department: A case report. | Vargas-Roa JC, Quintero-Vanegas S, Zuluaga-Gomez M, Gomez-Ortiz D, Gonzalez-Arroyave D, Ardila CM. | Biomed Rep | 10.3892/br.2023.1649 | 2023 | ||
| Pathogenicity | In Vitro and In Vivo Assessment of the Efficacy of Bromoageliferin, an Alkaloid Isolated from the Sponge Agelas dilatata, against Pseudomonas aeruginosa. | Pech-Puch D, Perez-Povedano M, Martinez-Guitian M, Lasarte-Monterrubio C, Vazquez-Ucha JC, Bou G, Rodriguez J, Beceiro A, Jimenez C. | Mar Drugs | 10.3390/md18060326 | 2020 | |
| Pathogenicity | Gold(I) and Gold(III) N-Heterocyclic Carbene Complexes as Antibacterial Agents and Inhibitors of Bacterial Thioredoxin Reductase. | Bussing R, Karge B, Lippmann P, Jones PG, Bronstrup M, Ott I. | ChemMedChem | 10.1002/cmdc.202100381 | 2021 | |
| Pathogenicity | Optimization of 4-Substituted Benzenesulfonamide Scaffold To Reverse Acinetobacter baumannii Serum-Adaptive Efflux Associated Antibiotic Tolerance. | Chojnacki M, Cao X, Young M, Fritz RN, Dunman PM, Flaherty DP. | ChemMedChem | 10.1002/cmdc.202000328 | 2020 | |
| Efficient Direct Nitrosylation of alpha-Diimine Rhenium Tricarbonyl Complexes to Structurally Nearly Identical Higher Charge Congeners Activable towards Photo-CO Release. | Nasiri Sovari S, Kolly I, Schindler K, Cortat Y, Liu SC, Crochet A, Pavic A, Zobi F. | Molecules | 10.3390/molecules26175302 | 2021 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #35541 | Collection of Institut Pasteur ; Curators of the CIP; CIP 52.235 |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive136203.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data